Keita Mori

6PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental biotechnology diagnostics (incl. biosensors)Visual effectsDeep learningMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLC.

|Feb 05, 2026
Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer.

Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro

|Dec 22, 2023
Resectability of Small Duodenal Tumors: A Randomized Controlled Trial Comparing Underwater Endoscopic Mucosal Resection and Cold Snare Polypectomy.

Kurato Miyazaki, Atsushi Nakayama, Motoki Sasaki

|Jul 14, 2023
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter.

Keita Mori, Akifumi Notsu, Keita Miura

|Sep 26, 2022
Artificial Intelligence-Powered Prediction of ALK Gene Rearrangement in Patients With Non-Small-Cell Lung Cancer.

Yukihiro Terada, Toshihiro Takahashi, Takamitsu Hayakawa

|Jan 25, 2022
Effects of infectious disease consultation and antimicrobial stewardship program at a Japanese cancer center: An interrupted time-series analysis.

Naoya Itoh, Nana Akazawa, Eri Kanawaku

Pageof 1

Frequent Collaborators

1 joint publications

Naoya Itoh

1 joint publications

Yukihiro Terada

1 joint publications

Akira Ono

1 joint publications

Yasuhisa Ohde